1. 21 FR 211.100(a). Accessed May 6, 2021. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiNy_rklbjwAhXvc98KHfjQD_8QFjAAegQIBhAD&url=https%3A%2F%2Fwww.accessdata.fda.gov%2Fscripts%2Fcdrh%2Fcfdocs%2Fcfcfr%2FCFRSearch.cfm%3Ffr%3D211.100&usg=AOvVaw0_pCW7Do6C2ba5bWFz5-XV
2. Statistical Methods for Dynamic Treatment Regimes
3. Chen, C.W., and C.Moore 2021. Role of Statistics in Pharmaceutical Development Using Quality-by-Design Approach – An FDA Perspective. Accessed May 6, 2021. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwior_z_0LXwAhVRJt8KHcUvA2EQFjABegQIAhAD&url=https%3A%2F%2Fww2.amstat.org%2Fmeetings%2Ffdaworkshop%2Fpresentations%2F2006%2F(1)Statistics%2520in%2520QbD%2520Stats%2520WS%252009-06.ppt&usg=AOvVaw1OymPPy2iqDVNa9dcw1X0